CN112425655A - Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and preparation method thereof - Google Patents
Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and preparation method thereof Download PDFInfo
- Publication number
- CN112425655A CN112425655A CN202011330904.2A CN202011330904A CN112425655A CN 112425655 A CN112425655 A CN 112425655A CN 202011330904 A CN202011330904 A CN 202011330904A CN 112425655 A CN112425655 A CN 112425655A
- Authority
- CN
- China
- Prior art keywords
- parts
- milk powder
- powder
- formula
- hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 147
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 55
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 33
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 31
- 201000001421 hyperglycemia Diseases 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 32
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 31
- 244000005700 microbiome Species 0.000 claims abstract description 28
- 150000001875 compounds Chemical class 0.000 claims abstract description 24
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 22
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 20
- 229920001202 Inulin Polymers 0.000 claims abstract description 20
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 20
- 229940029339 inulin Drugs 0.000 claims abstract description 20
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 19
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 19
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 19
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 19
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 19
- 239000011669 selenium Substances 0.000 claims abstract description 19
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 19
- 229960002675 xylitol Drugs 0.000 claims abstract description 19
- 235000010447 xylitol Nutrition 0.000 claims abstract description 19
- 239000000811 xylitol Substances 0.000 claims abstract description 19
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 16
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 16
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims description 30
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 24
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 24
- 235000008939 whole milk Nutrition 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 10
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 10
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 10
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 235000020251 goat milk Nutrition 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 235000020247 cow milk Nutrition 0.000 claims description 2
- 235000008476 powdered milk Nutrition 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000036772 blood pressure Effects 0.000 abstract description 10
- 208000024891 symptom Diseases 0.000 abstract description 7
- 235000019197 fats Nutrition 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000001603 reducing effect Effects 0.000 abstract description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 235000015816 nutrient absorption Nutrition 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 230000008855 peristalsis Effects 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 241001619444 Wolfiporia cocos Species 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 description 8
- 239000008267 milk Substances 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 6
- 239000000902 placebo Substances 0.000 description 4
- 229940068196 placebo Drugs 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- RZTAMFZIAATZDJ-HNNXBMFYSA-N 5-o-ethyl 3-o-methyl (4s)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC(Cl)=C1Cl RZTAMFZIAATZDJ-HNNXBMFYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960003580 felodipine Drugs 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and a preparation method thereof, wherein the formula milk powder comprises the following components in parts by weight: 80-100 parts of skimmed milk powder, 5-10 parts of haematococcus pluvialis powder, 10-15 parts of inulin, 2-4 parts of compound microorganisms, 10-20 parts of xylitol, 5-10 parts of maltodextrin, 3-5 parts of semen cassiae, 2-4 parts of poria cocos, 1-3 parts of alpha-linolenic acid and 0.2-0.5 part of organic selenium; according to the formula milk powder disclosed by the invention, through selection of the raw material components and the dosage, the formula milk powder not only has rich nutrient substances, but also can promote intestinal tract peristalsis, regulate intestines and stomach, reduce serum cholesterol, regulate nutrient absorption and improve the immunity of the organism, so that the aims of reducing blood pressure, blood fat and blood sugar are achieved, and the symptoms of patients with hypertension, hyperlipidemia and hyperglycemia are further remarkably improved.
Description
Technical Field
The invention relates to the technical field of milk powder, in particular to formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and a preparation method thereof.
Background
Along with the improvement of living standard, people eat better and better, so that more and more people with high blood fat, blood sugar and blood pressure in blood are caused, and the living quality of people is seriously influenced; therefore, it is particularly critical to develop a food which is rich in nutrition and has the efficacy of improving blood fat, blood sugar, blood pressure and the like in blood.
The milk powder is prepared by removing water from animal milk, and is suitable for storage. The milk powder is prepared by using fresh milk or goat milk as a raw material, removing almost all water in the milk by a freezing or heating method, adding a proper amount of vitamins, minerals and the like after drying, and is prepared into a brewing food which is easy to brew, convenient to carry, rich in abundant nutritional ingredients and popular with the masses.
Disclosure of Invention
The invention aims to provide the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and the preparation method thereof.
In order to achieve the above purpose of the present invention, the following technical solutions are adopted:
the invention provides a formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension, which comprises the following components in parts by weight:
80-100 parts of skimmed milk powder, 5-10 parts of haematococcus pluvialis powder, 10-15 parts of inulin, 2-4 parts of compound microorganisms, 10-20 parts of xylitol, 5-10 parts of maltodextrin, 3-5 parts of semen cassiae, 2-4 parts of poria cocos, 1-3 parts of alpha-linolenic acid and 0.2-0.5 part of organic selenium.
Preferably, the formula comprises the following components in parts by weight:
80-90 parts of skimmed milk powder, 6-8 parts of haematococcus pluvialis powder, 12-14 parts of inulin, 2-3 parts of compound microorganisms, 14-16 parts of xylitol, 6-8 parts of maltodextrin, 4-5 parts of semen cassiae, 2-3 parts of poria cocos, 1-2 parts of alpha-linolenic acid and 0.2-0.3 part of organic selenium.
Preferably, the formula comprises the following components in parts by weight:
90 parts of skimmed milk powder, 7 parts of haematococcus pluvialis powder, 13 parts of inulin, 3 parts of compound microorganisms, 15 parts of xylitol, 8 parts of maltodextrin, 4 parts of cassia seed, 3 parts of poria cocos, 2 parts of alpha-flax and 0.3 part of organic selenium.
Preferably, the formula milk powder also comprises 10-20 parts of whole milk powder.
Preferably, each of the complex microorganisms comprises:
5-10 parts of lactobacillus plantarum, 5-10 parts of lactic acid bacteria and 10-20 parts of lactobacillus rhamnosus.
Preferably, each of the complex microorganisms comprises:
8 parts of lactobacillus plantarum, 6 parts of lactobacillus and 15 parts of lactobacillus rhamnosus.
Preferably, the skimmed milk powder is skimmed goat milk powder and/or skimmed cow milk powder; the whole milk powder is whole goat milk powder and/or whole milk powder.
The second aspect of the invention provides a preparation method of the formula milk powder, which comprises the following steps:
(a) respectively pulverizing semen Cassiae and Poria to obtain semen Cassiae powder and Poria powder;
(b) uniformly mixing skim milk powder, haematococcus pluvialis powder, inulin, xylitol, maltodextrin, cassia seed powder, poria cocos powder, alpha-linolenic acid, organic selenium and whole milk powder to obtain a mixture;
(c) sterilizing the mixture, then adding the compound microorganism, mixing uniformly, and bagging to obtain the formula milk powder.
Preferably, the mesh particle size of the cassia seed powder and the tuckahoe powder is 200-300 meshes.
Preferably, the sterilization mode is ultra-high pressure sterilization.
Compared with the prior art, the invention has the beneficial effects that at least:
according to the formula milk powder disclosed by the invention, through selection of the raw material components and the dosage, the formula milk powder not only has rich nutrient substances, but also can promote intestinal tract peristalsis, regulate intestines and stomach, reduce serum cholesterol, regulate nutrient absorption and improve the immunity of the organism, so that the aims of reducing blood pressure, blood fat and blood sugar are achieved, and the symptoms of patients with hypertension, hyperlipidemia and hyperglycemia are further remarkably improved.
Detailed Description
The following describes embodiments of the present invention in detail with reference to the following embodiments. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby.
It is to be noted that, unless otherwise specified, technical or scientific terms used herein shall have the ordinary meaning as understood by those skilled in the art to which the invention pertains.
Example 1
Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension
The formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following components in parts by weight:
80 parts of skimmed milk powder, 10 parts of haematococcus pluvialis powder, 15 parts of inulin, 4 parts of compound microorganisms, 10 parts of xylitol, 10 parts of maltodextrin, 3 parts of semen cassiae, 4 parts of poria cocos, 1 part of alpha-linolenic acid and 0.5 part of organic selenium;
each part of the compound microorganism comprises:
5 parts of lactobacillus plantarum, 10 parts of lactic acid bacteria and 10 parts of lactobacillus rhamnosus.
Second, preparation method
The preparation method of the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following steps:
(a) respectively crushing the cassia seeds and the poria cocos to obtain cassia seed powder and poria cocos powder with the granularity of 200-300 meshes;
(b) uniformly mixing skim milk powder, haematococcus pluvialis powder, inulin, xylitol, maltodextrin, cassia seed powder, poria cocos powder, alpha-linolenic acid and organic selenium to obtain a mixture;
(c) and (3) sterilizing the mixture at ultrahigh pressure, then adding the compound microorganism, uniformly mixing and bagging to obtain the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension.
Example 2
Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension
The formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following components in parts by weight:
100 parts of skimmed milk powder, 5 parts of haematococcus pluvialis powder, 10 parts of inulin, 2 parts of compound microorganisms, 20 parts of xylitol, 5 parts of maltodextrin, 5 parts of semen cassiae, 2 parts of poria cocos, 3 parts of alpha-linolenic acid, 15 parts of whole milk powder and 0.2 part of organic selenium;
each part of the compound microorganism comprises:
10 parts of lactobacillus plantarum, 5 parts of lactobacillus and 20 parts of lactobacillus rhamnosus.
Second, preparation method
The preparation method of the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following steps:
(a) respectively crushing the cassia seeds and the poria cocos to obtain cassia seed powder and poria cocos powder with the granularity of 200-300 meshes;
(b) uniformly mixing skim milk powder, haematococcus pluvialis powder, inulin, xylitol, maltodextrin, cassia seed powder, poria cocos powder, alpha-linolenic acid, whole milk powder and organic selenium to obtain a mixture;
(c) and (3) sterilizing the mixture at ultrahigh pressure, then adding the compound microorganism, uniformly mixing and bagging to obtain the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension.
Example 3
Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension
The formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following components in parts by weight:
80 parts of skimmed milk powder, 8 parts of haematococcus pluvialis powder, 14 parts of inulin, 2 parts of compound microorganisms, 14 parts of xylitol, 8 parts of maltodextrin, 4 parts of cassia seed, 3 parts of poria cocos, 1 part of alpha-linolenic acid, 20 parts of whole milk powder and 0.3 part of organic selenium;
each part of the compound microorganism comprises:
8 parts of lactobacillus plantarum, 6 parts of lactobacillus and 12 parts of lactobacillus rhamnosus.
Second, preparation method
The preparation method of the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following steps:
(a) respectively crushing the cassia seeds and the poria cocos to obtain cassia seed powder and poria cocos powder with the granularity of 200-300 meshes;
(b) uniformly mixing skim milk powder, haematococcus pluvialis powder, inulin, xylitol, maltodextrin, cassia seed powder, poria cocos powder, alpha-linolenic acid, whole milk powder and organic selenium to obtain a mixture;
(c) and (3) sterilizing the mixture at ultrahigh pressure, then adding the compound microorganism, uniformly mixing and bagging to obtain the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension.
Example 4
Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension
The formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following components in parts by weight:
90 parts of skimmed milk powder, 6 parts of haematococcus pluvialis powder, 12 parts of inulin, 3 parts of compound microorganisms, 16 parts of xylitol, 6 parts of maltodextrin, 5 parts of cassia seed, 2 parts of poria cocos, 2 parts of alpha-linolenic acid, 10 parts of whole milk powder and 0.2 part of organic selenium;
each part of the compound microorganism comprises:
6 parts of lactobacillus plantarum, 8 parts of lactic acid bacteria and 16 parts of lactobacillus rhamnosus.
Second, preparation method
The preparation method of the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following steps:
(a) respectively crushing the cassia seeds and the poria cocos to obtain cassia seed powder and poria cocos powder with the granularity of 200-300 meshes;
(b) uniformly mixing skim milk powder, haematococcus pluvialis powder, inulin, xylitol, maltodextrin, cassia seed powder, poria cocos powder, alpha-linolenic acid, whole milk powder and organic selenium to obtain a mixture;
(c) and (3) sterilizing the mixture at ultrahigh pressure, then adding the compound microorganism, uniformly mixing and bagging to obtain the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension.
Example 5
Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension
The formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following components in parts by weight:
90 parts of skimmed milk powder, 7 parts of haematococcus pluvialis powder, 13 parts of inulin, 3 parts of compound microorganisms, 15 parts of xylitol, 8 parts of maltodextrin, 4 parts of cassia seed, 3 parts of poria cocos, 2 parts of alpha-flax, 15 parts of whole milk powder and 0.3 part of organic selenium;
each part of the compound microorganism comprises:
8 parts of lactobacillus plantarum, 6 parts of lactobacillus and 15 parts of lactobacillus rhamnosus.
Second, preparation method
The preparation method of the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension comprises the following steps:
(a) respectively crushing the cassia seeds and the poria cocos to obtain cassia seed powder and poria cocos powder with the granularity of 200-300 meshes;
(b) uniformly mixing skim milk powder, haematococcus pluvialis powder, inulin, xylitol, maltodextrin, cassia seed powder, poria cocos powder, alpha-linolenic acid, whole milk powder and organic selenium to obtain a mixture;
(c) and (3) sterilizing the mixture at ultrahigh pressure, then adding the compound microorganism, uniformly mixing and bagging to obtain the formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension.
Comparative example 1
The comparative example is a formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension, which is basically the same as the formula milk powder in example 5 except that haematococcus pluvialis powder is replaced by inulin with the same fraction.
The above formula was prepared in the same manner as in example 5.
Comparative example 2
The comparative example is a formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension, and the formula milk powder is basically the same as the formula milk powder in example 5, except that lactobacillus plantarum is replaced by lactobacillus rhamnosus with the same fraction.
The above formula was prepared in the same manner as in example 5.
Examples of the experiments
Respectively obtaining formula milk powder prepared in examples 1-5 and comparative examples 1-2;
240 volunteers are characterized, each volunteer has symptoms of dizziness, headache and palpitation caused by hypertension, under the condition that the volunteers are unconscious, the volunteers are randomly divided into 8 groups of 30 people each, wherein the 1 st to 7 th groups respectively eat the formula milk powder prepared in the examples 1 to 5 and the comparative examples 1 to 2 in sequence, the 8 th group takes the same amount of placebo (skim milk powder), and simultaneously, each volunteer normally takes half-reduced felodipine tablet antihypertensive drugs every day;
the amount of the formula milk powder and the placebo taken by each volunteer is 1 bag per day, each bag is 25g, the milk powder and the placebo are taken with warm boiled water at 40-45 ℃, the administration lasts for 1 month, the blood pressure of each volunteer is measured and counted in the morning every day during the administration period, and whether uncomfortable symptoms appear every day is counted;
and (4) judging the standard:
(1) the effect is shown: the blood pressure is not more than 1 time; the discomfort symptom is less than or equal to 1 time;
(2) the method has the following advantages: the blood pressure is not more than 3 times and not less than 2 times; the discomfort symptom is less than or equal to 3 times and more than or equal to 2 times;
(3) and (4) invalidation: the blood pressure is higher than or equal to 4 times or the discomfort symptom is higher than or equal to 4 times.
According to the evaluation criteria, each volunteer was evaluated, and the evaluation results are shown in table 1:
TABLE 1
As can be seen from Table 1:
each of the examples and the control example was able to significantly lower blood pressure compared to the placebo group; compared with the milk powder of the control example, the milk powder of the embodiment of the application has more excellent blood pressure reducing effect and can better improve related diseases caused by hypertension.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention, and they should be construed as being included in the following claims and description.
Claims (10)
1. The formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension is characterized by comprising the following components in parts by weight:
80-100 parts of skimmed milk powder, 5-10 parts of haematococcus pluvialis powder, 10-15 parts of inulin, 2-4 parts of compound microorganisms, 10-20 parts of xylitol, 5-10 parts of maltodextrin, 3-5 parts of semen cassiae, 2-4 parts of poria cocos, 1-3 parts of alpha-linolenic acid and 0.2-0.5 part of organic selenium.
2. The formula according to claim 1, comprising the following components in parts by weight:
80-90 parts of skimmed milk powder, 6-8 parts of haematococcus pluvialis powder, 12-14 parts of inulin, 2-3 parts of compound microorganisms, 14-16 parts of xylitol, 6-8 parts of maltodextrin, 4-5 parts of semen cassiae, 2-3 parts of poria cocos, 1-2 parts of alpha-linolenic acid and 0.2-0.3 part of organic selenium.
3. The formula according to claim 1, comprising the following components in parts by weight:
90 parts of skimmed milk powder, 7 parts of haematococcus pluvialis powder, 13 parts of inulin, 3 parts of compound microorganisms, 15 parts of xylitol, 8 parts of maltodextrin, 4 parts of cassia seed, 3 parts of poria cocos, 2 parts of alpha-flax and 0.3 part of organic selenium.
4. The formula of claim 1, further comprising 10-20 parts of whole milk powder.
5. The formula according to any one of claims 1 to 4, wherein each portion of the complex microorganisms comprises:
5-10 parts of lactobacillus plantarum, 5-10 parts of lactic acid bacteria and 10-20 parts of lactobacillus rhamnosus.
6. The formula according to claim 5, wherein each portion of said complex microorganisms comprises:
8 parts of lactobacillus plantarum, 6 parts of lactobacillus and 15 parts of lactobacillus rhamnosus.
7. The formula of any one of claims 1 to 4, wherein the skimmed milk powder is skimmed goat milk powder and/or skimmed cow milk powder; the whole milk powder is whole goat milk powder and/or whole milk powder.
8. The method for preparing the formula milk powder of any one of claims 1 to 7, which is characterized by comprising the following steps:
(a) respectively pulverizing semen Cassiae and Poria to obtain semen Cassiae powder and Poria powder;
(b) uniformly mixing skim milk powder, haematococcus pluvialis powder, inulin, xylitol, maltodextrin, cassia seed powder, poria cocos powder, alpha-linolenic acid, organic selenium and whole milk powder to obtain a mixture;
(c) sterilizing the mixture, then adding the compound microorganism, mixing uniformly, and bagging to obtain the formula milk powder.
9. The preparation method according to claim 8, wherein the mesh size of the cassia seed powder and the poria cocos powder is 200-300 meshes.
10. The method according to claim 9, wherein the sterilization means is ultra-high pressure sterilization.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011330904.2A CN112425655A (en) | 2020-11-24 | 2020-11-24 | Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011330904.2A CN112425655A (en) | 2020-11-24 | 2020-11-24 | Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112425655A true CN112425655A (en) | 2021-03-02 |
Family
ID=74692943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011330904.2A Pending CN112425655A (en) | 2020-11-24 | 2020-11-24 | Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112425655A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113812464A (en) * | 2021-08-10 | 2021-12-21 | 美庐生物科技股份有限公司 | Formula of milk powder helpful for preventing hypertension, hyperglycemia and hyperlipidemia of middle-aged and old people and preparation method of milk powder |
| CN113951508A (en) * | 2021-12-06 | 2022-01-21 | 武汉酷尔生物科技有限公司 | Food composition for reducing high blood pressure, high blood sugar and high blood fat |
Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102396703A (en) * | 2010-09-10 | 2012-04-04 | 上海爱优格生物科技有限公司 | Lactobacillus composition with function for preventing children hand-foot-mouth disease, preparation method thereof, and application thereof |
| CN104054826A (en) * | 2014-06-26 | 2014-09-24 | 江西雄鹰乳业有限公司 | Milk powder capable of preventing and lowering hyperlipidemia, hyperglycemia and hypertension |
| CN104305225A (en) * | 2014-09-28 | 2015-01-28 | 安徽珠峰生物科技有限公司 | Blood sugar-reducing composite protein powder and preparation method thereof |
| CN104522828A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment healthcare solid drink and preparation process thereof |
| CN104694409A (en) * | 2013-12-06 | 2015-06-10 | 深圳华大基因科技有限公司 | Lactobacillus plantarum and uses thereof |
| CN106172795A (en) * | 2016-06-16 | 2016-12-07 | 呼伦贝尔海乳乳业有限责任公司 | A kind of functional milk tea powder resisting haze |
| CN106473145A (en) * | 2015-08-28 | 2017-03-08 | 哈尔滨鑫红菊食品科技有限公司 | A kind of full nutrient protein flour producing process for adding isomalt and haematococcus pluvialis powder |
| CN106615218A (en) * | 2016-12-30 | 2017-05-10 | 北京三元食品股份有限公司 | Yoghurt powder, yoghurt formula powder and production method of yoghurt powder |
| CN107251947A (en) * | 2017-06-02 | 2017-10-17 | 杭州鑫伟低碳技术研发有限公司 | A kind of Astaxanthin In Haematococcus Pluvialis milk and preparation method thereof |
| CN108065392A (en) * | 2017-12-05 | 2018-05-25 | 杭州鑫伟低碳技术研发有限公司 | A kind of composition of assisting in treating hypertension, hyperlipidemic conditions |
| CN108991327A (en) * | 2018-07-24 | 2018-12-14 | 北京奥维森基因健康科技有限公司 | A kind of probiotics solid beverage and preparation method thereof |
| CN109122869A (en) * | 2018-08-08 | 2019-01-04 | 陕西英童乳业有限公司 | A kind of formula milk and preparation method thereof with lower hyperlipidemia, hypertension, hyperglycemia effect |
| CN111771984A (en) * | 2020-07-14 | 2020-10-16 | 吴善艳 | Formula milk powder with beauty treatment effect and preparation method thereof |
-
2020
- 2020-11-24 CN CN202011330904.2A patent/CN112425655A/en active Pending
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102396703A (en) * | 2010-09-10 | 2012-04-04 | 上海爱优格生物科技有限公司 | Lactobacillus composition with function for preventing children hand-foot-mouth disease, preparation method thereof, and application thereof |
| CN104694409A (en) * | 2013-12-06 | 2015-06-10 | 深圳华大基因科技有限公司 | Lactobacillus plantarum and uses thereof |
| CN104054826A (en) * | 2014-06-26 | 2014-09-24 | 江西雄鹰乳业有限公司 | Milk powder capable of preventing and lowering hyperlipidemia, hyperglycemia and hypertension |
| CN104305225A (en) * | 2014-09-28 | 2015-01-28 | 安徽珠峰生物科技有限公司 | Blood sugar-reducing composite protein powder and preparation method thereof |
| CN104522828A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment healthcare solid drink and preparation process thereof |
| CN106473145A (en) * | 2015-08-28 | 2017-03-08 | 哈尔滨鑫红菊食品科技有限公司 | A kind of full nutrient protein flour producing process for adding isomalt and haematococcus pluvialis powder |
| CN106172795A (en) * | 2016-06-16 | 2016-12-07 | 呼伦贝尔海乳乳业有限责任公司 | A kind of functional milk tea powder resisting haze |
| CN106615218A (en) * | 2016-12-30 | 2017-05-10 | 北京三元食品股份有限公司 | Yoghurt powder, yoghurt formula powder and production method of yoghurt powder |
| CN107251947A (en) * | 2017-06-02 | 2017-10-17 | 杭州鑫伟低碳技术研发有限公司 | A kind of Astaxanthin In Haematococcus Pluvialis milk and preparation method thereof |
| CN108065392A (en) * | 2017-12-05 | 2018-05-25 | 杭州鑫伟低碳技术研发有限公司 | A kind of composition of assisting in treating hypertension, hyperlipidemic conditions |
| CN108991327A (en) * | 2018-07-24 | 2018-12-14 | 北京奥维森基因健康科技有限公司 | A kind of probiotics solid beverage and preparation method thereof |
| CN109122869A (en) * | 2018-08-08 | 2019-01-04 | 陕西英童乳业有限公司 | A kind of formula milk and preparation method thereof with lower hyperlipidemia, hypertension, hyperglycemia effect |
| CN111771984A (en) * | 2020-07-14 | 2020-10-16 | 吴善艳 | Formula milk powder with beauty treatment effect and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 江省蓉: "《图解保健食品全书》", 31 May 2015, 湖南科学技术出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113812464A (en) * | 2021-08-10 | 2021-12-21 | 美庐生物科技股份有限公司 | Formula of milk powder helpful for preventing hypertension, hyperglycemia and hyperlipidemia of middle-aged and old people and preparation method of milk powder |
| CN113951508A (en) * | 2021-12-06 | 2022-01-21 | 武汉酷尔生物科技有限公司 | Food composition for reducing high blood pressure, high blood sugar and high blood fat |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101496579B (en) | Special diet and foodstuffs formula containing small peptide for tumor patient | |
| CN108812909B (en) | Complementary food nutritional supplement for improving monophagia or anorexia and preparation method thereof | |
| CN105249452A (en) | Fruit and vegetable enzyme powder with weight reducing function and preparation method thereof | |
| CN102940154B (en) | Feed for improving productivity of newly born dairy calf | |
| CN104187709A (en) | Total nutrient formula food suitable for patients having obesity or fat-reducing operation | |
| KR20090018031A (en) | Guava leaf extract powder and method for production thereof | |
| CN108935709A (en) | A kind of probiotics goat milk piece and preparation method thereof | |
| CN112425655A (en) | Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and preparation method thereof | |
| CN110122744A (en) | A kind of quinoa nutrient powder and preparation method thereof | |
| CN108882730A (en) | A kind of drink adjusting human body stomach function | |
| CN104921238A (en) | Toxin-removing and beauty-maintaining health-care beverage and preparation method thereof | |
| KR101515253B1 (en) | Agent for promoting the secretion of and/or suppressing decrease of adiponectin | |
| CN106472684A (en) | A kind of milk product | |
| CN104187650A (en) | Full-nutrition formula food suitable for people with specific endowment constitution | |
| KR20040045146A (en) | the natural medicines for the removing hangover and its healthy foods | |
| CN112472733A (en) | A flos Puerariae Lobatae extract for promoting calcium oral absorption | |
| CN106472681A (en) | A kind of milk product | |
| CN105341911A (en) | Processing method for pleurotus eryngii and rhizoma smilacis glabrae fermentation drink | |
| CN108477460A (en) | A kind of composition and preparation method thereof having effect of relaxing bowel | |
| RU2341276C1 (en) | Method of gastrointestinal disturbance prevention in newborn calfs | |
| CN105076816B (en) | A kind of pet dog snacks pumpkin item and preparation method thereof | |
| CN108522839A (en) | A kind of fermented feed and preparation method thereof of enhancing goat immune power | |
| CN117224614B (en) | Composite ferment with qi-tonifying and blood-nourishing effects, and preparation method and application thereof | |
| CN106578587A (en) | Young pigeon disease prevention feed and preparation method thereof | |
| CN106578051A (en) | Lactic acid bacteria fruit juice beverage and production method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |